Table 3 Characteristics of ALS patients (N = 293) with mortality follow-up by survival status.
NDeceased | Deceased | NSurvived | Survived | |
|---|---|---|---|---|
Age (years), mean (SD) | 243 | 66.5 (10.5) | 50 | 60.5 (11.7) |
Sex | 243 | 50 | ||
Male, N (%) | 138 (56.8) | 38 (76.0) | ||
BMI (kg/mb), mean (SD) | 243 | 24.5 (4.0) | 50 | 24.8 (4.5) |
Diagnostic delay (month), median (Q1, Q3) | 243 | 5.0 (2.7, 8.5) | 50 | 6.0 (2.5, 11.1) |
ALS-FRS, median (Q1, Q3) | 242 | 38.5 (34, 42) | 50 | 41 (38, 45) |
IGF-1 (ng/ml), median (Q1, Q3) | 243 | 101.0 (82.2,118.0) | 50 | 105.5 (74.6, 137.0) |
